Reset Pharmaceuticals Appoints Innes Meldrum as President and Chief Executive Officer
NEW YORK, Jan. 05, 2023 (GLOBE NEWSWIRE) — Reset Pharmaceuticals, Inc. (Reset Pharma), a privately…
News
Aligos Therapeutics on Track to Complete Phase 2-Enabling Activities in 2023 for its Clinically Validated THR-ß Drug Candidate for NASH, ALG-055009
– Final cohort of Phase 1 study projected to be complete in H1 2023 –…
World Orphan Drug Alliance Announces Agreement with Theratechnologies for the Distribution of EGRIFTA SV
Under the agreement, the World Orphan Drug Alliance (WODA) has obtained exclusive distribution rights to…
ORYZON to Give Updates on Corporate Progress in January
6th Sachs Annual Neuroscience Innovation Forum 12th Annual LifeSci Advisors Corporate Access Event 41st Annual…
Ventyx Biosciences to Host R&D Event on January 26, 2023
ENCINITAS, Calif., Jan. 05, 2023 (GLOBE NEWSWIRE) — Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a…
Cogent Biosciences Announces Presentation at the 41st Annual J.P. Morgan Healthcare Conference
WALTHAM, Mass. and BOULDER, Colo., Jan. 05, 2023 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT),…
Intercept Pharmaceuticals to Present at J.P. Morgan 41st Annual Healthcare Conference on January 12, 2023
MORRISTOWN, N.J., Jan. 05, 2023 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical…
ShapeTX to Showcase Groundbreaking Advances in CNS in vivo RNA Editing, CNS-Targeting AAVs, and TruStable™ AAV Manufacturing at the J.P. Morgan 41st Annual Healthcare Conference
SEATTLE, Jan. 05, 2023 (GLOBE NEWSWIRE) — ShapeTX today announced Francois Vigneault, Ph.D., Co-founder and…
Black Diamond Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass. and NEW YORK, Jan. 05, 2023 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc….
Revolo Biotherapeutics Completes Enrollment in Phase 2 Trial of ‘1104 in Allergic Disease
Topline data anticipated in Q2 2023 NEW ORLEANS and LOS ANGELES and LONDON, Jan. 05,…
Paratek Pharmaceuticals Receives $36.4 Million Milestone Payment Associated with the Second Procurement of NUZYRA® (omadacycline) under BARDA Project BioShield Contract
Total Procurement-related Revenue Recognition of $38.1 Million to Paratek in December 2022 Procurement Triggered by…
Volta Medical Secures €36M in Series B Funding to Support Adoption of its AI Software for Cardiac Ablation, New CFO Introduced
New round of financing led by Vensana Capital will support technology platform expansion and further…
Noema Pharma to Attend and Present at 41st Annual J.P. Morgan Healthcare Conference in San Francisco
BASEL, Switzerland and BOSTON, Jan. 05, 2023 (GLOBE NEWSWIRE) — Noema Pharma, a clinical-stage biotech…
MBX Biosciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
CARMEL, Ind., Jan. 05, 2023 (GLOBE NEWSWIRE) — MBX Biosciences, Inc., a clinical stage biopharmaceutical…
Salarius Pharmaceuticals Announces Issuance of New U.S. Patent for Next-Generation Targeted Protein Degraders
Expands intellectual property portfolio with composition-of-matter patent protection for second novel molecular glue Protein degrader…
AltruBio to Present at Biotech Showcase™ 2023
SAN FRANCISCO, Jan. 05, 2023 (GLOBE NEWSWIRE) — AltruBio Inc. (“AltruBio” or “the Company”), a…
Vaxxinity to Present at the 2023 J.P. Morgan Healthcare Conference
DALLAS, Jan. 05, 2023 (GLOBE NEWSWIRE) — Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering…
Minovia Therapeutics appoints Maha Radhakrishnan, Chief Medical Officer at Biogen, as board member
TIRAT HACARMEL, Israel, Jan. 05, 2023 (GLOBE NEWSWIRE) — Minovia Therapeutics (Minovia), a clinical-stage company focused on…
F2G to Present at Biotech Showcase™ 2023
MANCHESTER, United Kingdom, Jan. 05, 2023 (GLOBE NEWSWIRE) — F2G Ltd. today announced that the…
Surface Oncology Announces First Patient Dosed in a Phase 1/2 Study Evaluating SRF114, a Potential Best-In-Class Anti-CCR8 Antibody, in Patients with Advanced Solid Tumors
SRF114 is designed to preferentially deplete CCR8+ Treg cells within the tumor microenvironment and has…